September 14, 2016
Merck (Darmstadt, Germany, known as EMD Serono in the US) this week announced the recipients of the Grant for Growth Innovation (GGI) at an award presentation European Society for Pediatric Endocrinology (ESPE) Meeting in Paris, France. The GGI program was initiated to support the advancement of understanding of the field of growth. A total grant of up to €400,000 per year, divided between up to three research proposals, is awarded to the selected projects. This year's winning projects are based in Australia, Italy, and Brazil, and are as follows:
For further information about the GGI and how to apply for next year's grants, please visit
http://www.grantforgrowthinnovation.org
Can Data and AI Deliver Whole-Person Health?
July 9th 2024Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.